143 related articles for article (PubMed ID: 24124137)
1. Anticoagulation without monitoring.
Chandler WL
Am J Clin Pathol; 2013 Nov; 140(5):606-7. PubMed ID: 24124137
[No Abstract] [Full Text] [Related]
2. New directions in anticoagulation.
Alpert JS
Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912
[No Abstract] [Full Text] [Related]
3. [New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
Oberhofer E
MMW Fortschr Med; 2015 Jan; 157(1):24. PubMed ID: 25743289
[No Abstract] [Full Text] [Related]
4. A new era for anticoagulation in atrial fibrillation.
Mega JL
N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
[No Abstract] [Full Text] [Related]
5. Disadvantages of VKA and requirements for novel anticoagulants.
Shameem R; Ansell J
Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
[TBL] [Abstract][Full Text] [Related]
6. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
Steurer J
Praxis (Bern 1994); 2014 Aug; 103(17):1032. PubMed ID: 25146949
[No Abstract] [Full Text] [Related]
7. [Introduction].
Valle Bernad R
Rev Clin Esp; 2012 Jan; 212 Suppl 1():1-2. PubMed ID: 23117645
[No Abstract] [Full Text] [Related]
8. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
9. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
10. Defining non-valvular atrial fibrillation while selecting anticoagulation therapy.
Garg P; Ripley DP
Br J Hosp Med (Lond); 2015 Feb; 76(2):66-7. PubMed ID: 25671468
[No Abstract] [Full Text] [Related]
11. Atrial fibrillation choices. Picking an anti-clotting drug.
Mayo Clin Health Lett; 2014 Jun; 32(6):4-5. PubMed ID: 25029747
[No Abstract] [Full Text] [Related]
12. Treatment of atrial fibrillation.
Med Lett Drugs Ther; 2014 Jul; 56(1446):53-8. PubMed ID: 25046325
[No Abstract] [Full Text] [Related]
13. [Clinical management of the new anticoagulants].
Zapata Wainberg G; Ximénez-Carrillo Rico A; Vivancos Mora J
Neurologia; 2012 Mar; 27 Suppl 1():33-8. PubMed ID: 22682208
[TBL] [Abstract][Full Text] [Related]
14. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
Avorn J
Circulation; 2013 Aug; 128(7):745-8. PubMed ID: 23940388
[No Abstract] [Full Text] [Related]
15. Novel anticoagulants make life easier for patients with atrial fibrillation. The new drugs have many advantages over Coumadin--but they aren't perfect--and they have no antidotes in case of overdose.
Duke Med Health News; 2014 Jan; 20(1):1-2. PubMed ID: 25632507
[No Abstract] [Full Text] [Related]
16. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
Stöllberger C; Finsterer J
Thromb Haemost; 2013 Sep; 110(3):496-500. PubMed ID: 23803875
[No Abstract] [Full Text] [Related]
17. New antithrombotic drugs and European approval processes.
Marijon E; Fauchier L; Le Heuzey JY
Lancet; 2011 Aug; 378(9792):662-3. PubMed ID: 21856473
[No Abstract] [Full Text] [Related]
18. Anticoagulating obese patients in the modern era.
Patel JP; Roberts LN; Arya R
Br J Haematol; 2011 Oct; 155(2):137-49. PubMed ID: 21848880
[TBL] [Abstract][Full Text] [Related]
19. Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
Diener HC
Thromb Haemost; 2013 Sep; 110(3):493-5. PubMed ID: 23803957
[No Abstract] [Full Text] [Related]
20. I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
Duke Med Health News; 2012 Jan; 18(1):8. PubMed ID: 22324070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
